Experimental models of Alzheimer's disease (AD) are critical to gaining a better
understanding of pathogenesis and to assess the potential of novel therapeutic approaches …

Accumulation of toxic protein aggregates—amyloid-β (Aβ) plaques and
hyperphosphorylated tau tangles—is the pathological hallmark of Alzheimer disease (AD) …

To assess the value of exosomal miRNAs as biomarkers for Alzheimer disease (AD), the
expression of microRNAs was measured in a plasma fraction enriched in exosomes by …

Alzheimer's disease (AD) is the most prevalent form of dementia worldwide and is an
emerging global epidemic. It is characterized by an imbalance between production and …

MicroRNAs (miRNAs) are small non-coding RNA which have been shown to regulate gene
expression. The alteration ofmiRNAs expression has been associated with several …

Alzheimer's disease (AD) is the leading cause of dementia and the most common
neurodegenerative disease in the elderly. Furthermore, AD has provided the most positive …

The human brain stands as an intricate organ, embodying a nexus of structure, function,
development, and diversity. This review delves into the multifaceted landscape of the brain …

Alzheimer's disease (AD) is a devastating neurodegenerative disorder that is growing in
prevalence globally. It is the only major cause of death without any effective …

Alzheimer's disease (AD) is a multifactorial, age-related neurological disease characterized
by complex pathophysiological dynamics taking place at multiple biological levels, including …

Alzheimer's disease (AD) is one of the most common neurodegenerative diseases, with
increasing prevalence affecting millions of people worldwide. Currently, only autopsy is able …